Vitamin D Pilot Study in Patients With Multiple Sclerosis

Phase 1CompletedNCT01257958

University of Wisconsin, Madison

Overview

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * relapsing remitting MS Exclusion Criteria: * MRI contraindicated

UW-Madison

Madison, Wisconsin, United States

MRI Measure of new active lesions, observation vs. treatment

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.